Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-30 @ 4:52 PM
Study NCT ID:
NCT00100932
Status:
COMPLETED
Last Update Posted:
2012-03-27
First Post:
2005-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-01-07
First Submit QC Date:
None
Study First Post Date:
2005-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-12-26
Results First Submit QC Date:
None
Results First Post Date:
2012-01-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-22
Last Update Post Date:
2012-03-27
Last Update Post Date Type:
ESTIMATED